Posterior reversible encephalopathy syndrome in childhood cancer

Annals of Oncology

Volumn 22, Issue 2, 2011, Pages 472-478

  de Laat, P ^a   te Winkel, M L ^a   Devos, A S ^a   Catsman Berrevoets, C E ^a   Pieters, R ^a   van den Heuvel Eibrink, M M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Childhood cancer; Hypertension; MRI; Neurotoxicity; Posterior reversible encephalopathy syndrome; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ASPARAGINASE MACROGOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DIURETIC AGENT; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; ATAXIA; BRAIN VENTRICLE PERITONEUM SHUNT; BURKITT LYMPHOMA; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DIZZINESS; DRUG MEGADOSE; EWING SARCOMA; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MYDRIASIS; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SOLID TUMOR; TREMOR; VISUAL DISORDER; WALKING DIFFICULTY;

EID: 79251564434     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq382     Document Type: Article

References (32)

1. Antunes NL. Seizures in children with systemic cancer. Pediatr Neurol 2003; 28: 190-193.
2. Huang LT, Hsiao CC, Weng HH, Lui CC. Neurologic complications of pediatric systemic malignancies. J Formos Med Assoc 1996; 95: 209-212.
3. Weyl-Ben Arush M, Stein M, Perez-Nachum M et al. Neurologic complications in pediatric solid tumors. Oncology 1995; 52: 89-92.
4. Antunes NL, De Angelis LM. Neurologic consultations in children with systemic cancer. Pediatr Neurol 1999; 20: 121-124.
5. DiMario FJ Jr, Packer RJ. Acute mental status changes in children with systemic cancer. Pediatrics 1990; 85: 353-360.
6. Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334: 494-500.
7. Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol 2000; 21: 1199-1206.
8. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: three names for an old syndrome. J Child Neurol 1999; 14: 277-281.
9. Lamy C, Oppenheim C, Meder JF, Mas JL. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004; 14: 89-96.
10. Veerman AJ, Kamps WA, van den Berg H et al. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004). Lancet Oncol 2009; 10: 957-966.
11. Dutch Childhood Oncology Group (DCOG). Protocol information ALL10. http://www.skion.nl/protocol/all10. (November 20, 2009, date last accessed).
12. ClinicalTrials.gov. ALLR3: an International Collaborative Trial for Relapsed and Refractory Acute Lymphoblastic Leukaemia (ALL). http://clinicaltrials.gov/ct2/show/NCT00967057. (November 20, 2009, date last accessed).
13. Juergens C, Weston C, Lewis I et al. Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial. Pediatr Blood Cancer 2006; 47: 22-29.
14. D'Angelo P, Farruggia P, Lo Bello A et al. Reversible posterior leukoencephalopathy syndrome: report of 2 simultaneous cases in children. J Pediatr Hematol Oncol 2006; 28: 177-181.
15. Cooney MJ, Bradley WG, Symko SC et al. Hypertensive encephalopathy: complication in children treated for myeloproliferative disorders-report of three cases. Radiology 2000; 214: 711-716.
16. Gupta A, Swaroop C, Rastogi R et al. Simultaneous occurrence of posterior reversible leukoencephalopathy syndrome in two cases of childhood acute lymphoblastic leukemia induction chemotherapy. Pediatr Hematol Oncol 2008; 25: 351-358.
17. Honkaniemi J, Kahara V, Dastidar P et al. Reversible posterior leukoencephalopathy after combination chemotherapy. Neuroradiology 2000; 42: 895-899.
18. Hourani R, Abboud M, Hourani M et al. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children. Neuropediatrics 2008; 39: 46-50.
19. Kaito E, Terae S, Kobayashi R et al. The role of tumor lysis in reversible posterior leukoencephalopathy syndrome. Pediatr Radiol 2005; 35: 722-727.
20. Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001; 24: 361-364.
21. Lucchini G, Grioni D, Colombini A et al. Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer 2008; 51: 629-633.
22. Morris EB, Laningham FH, Sandlund JT, Khan RB. Posterior reversible encephalopathy syndrome in children with cancer. Pediatr Blood Cancer 2007; 48: 152-159.
23. Niyadurupola N, Burnett CA, Allen LE. Reversible posterior leucoencephalopathy syndrome: a cause of temporary cortical blindness. Br J Ophthalmol 2005; 89: 924-925.
24. Norman JK, Parke JT, Wilson DA, McNall-Knapp RY. Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2007; 49: 198-203.
25. Rathi B, Azad RK, Vasudha N et al. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia. Pediatr Neurosurg 2002; 37: 203-205.
26. Sanchez-Carpintero R, Narbona J, Lopez de Mesa R et al. Transient posterior encephalopathy induced by chemotherapy in children. Pediatr Neurol 2001; 24: 145-148.
27. Shin RK, Stern JW, Janss AJ et al. Reversible posterior leukoencephalopathy during the treatment of acute lymphoblastic leukemia. Neurology 2001; 56: 388-391.
28. Suminoe A, Matsuzaki A, Kira R et al. Reversible posterior leukoencephalopathy syndrome in children with cancers. J Pediatr Hematol Oncol 2003; 25: 236-239.
29. Won SC, Kwon SY, Han JW et al. Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. J Pediatr Hematol Oncol 2009; 31: 505-508.
30. Ay H, Buonanno FS, Schaefer PW et al. Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI. Neurology 1998; 51: 1369-1376.
31. Antunes NL, Small TN, George D et al. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 1999; 20: 241-243.
32. Prasad N, Gulati S, Gupta RK et al. Is reversible posterior leukoencephalopathy with severe hypertension completely reversible in all patients? Pediatr Nephrol 2003; 18: 1161-1166.